|
IntraSite Conformable is a conformable hydrogel dressing which combines the advantages of IntraSite Gel with a non-woven dressing to aid in the gentle packing of deep, shallow, open or undermined wounds. The non-woven substrate ensures the gel remains in close contact with the entire wound surface. It is suitable for use in necrotic, sloughy and granulating wounds, and helps create a moist wound environment to facilitate healing.
BENEFITS
Debriding and Desloughing Action:
- IntraSite Conformable contains IntraSite Gel which has a gentle yet effective debriding and desloughing action. The gel rehydrates necrotic tissue and absorbs slough and wound exudate.
- Fluid handling properties reduce the frequency of dressing changes.
Moist-wound Healing:
- IntraSite Conformable helps to promote and maintain a moist wound environment. The presence of IntraSite Gel helps to prevents adherence to the wound surface, allowing easy dressing changes without damaging fragile new granulation tissue.
- IntraSite Conformable is safe for use throughout the wound healing process.
Conformable:
- The non-woven dressing is both soft and conformable – conforming easily to awkward wound shapes and keeping the gel where it is needed (in contact with the wound surface).
Convenient and ready to use:
- IntraSite Conformable is convenient and ready to use, offering an alternative delivery system for IntraSite Gel. The easy-peel pack is customer friendly and allows aseptic application.
Indications:
IntraSite Conformable is indicated for use in open wounds e.g. pressure sores, surgical wounds, malignant wounds healing by secondary intention, radiation burns and excoriated skin. It is especially useful for the packing of deep cavity wounds. It can be used on infected wounds under medical supervision.
Contraindications / Precautions:
Known sensitivity to IntraSite Conformable or any of its ingredients.
IntraSite Conformable should be used with care in the vicinity of the eye.
Avoid ingestion.
Avoid use on cracked nipples 
Intrasite may be applied to many different types of wound, including leg ulcers, pressure sores , surgical wounds and extravasation injuries. It is of particular value in the treatment of dry, sloughy, or necrotic wounds, promoting rapid debridement by facilitating rehydration and autolysis of dead tissue. In the management of granulating wounds, Intrasite prevent desiccation, and thus facilitates re-epithelialisation. The gel can form a useful vehicle for the topical application of antimicrobial agents such as metronidazole. Such preparations may be used, in combination with systemic therapy, for the management of wound odour caused by infection with sensitive organisms.
Description
Intrasite, is a colourless transparent aqueous gel, which contains 2.3% of a modified carboxymethylcellulose (CMC) polymer together with propylene glycol (20%) as a humectant and preservative. When placed in contact with a wound, the dressing absorbs excess exudate and produces a moist environment at the surface of the wound, without causing tissue maceration.
Contra-indications:
Although there are no known contra-indications to the use of Intrasite as a topical wound dressing, the material is not ideally suited for application to wounds that are exuding very heavily.
Warnings
Intrasite contains propylene glycol, which has been reported to be a potential irritant and sensitising agent in a very small number of patients. If a patient should exhibit any signs or symptoms of an adverse reaction to Intrasite, treatment should be discontinued at once. Each container should only be used for a single patient, and any unused gel should be discarded.
Dosage
Intrasite should be introduced into the wound to a minimum depth of 5 mm, and covered with a sterile secondary dressing. Any unused dressing should be discarded. The selection of the secondary dressing will be governed by the condition of the wound. If significant quantities of exudate are anticipated, a simple absorbent pad may be used, held in position with tape or a bandage, as appropriate. On lightly exuding wounds, a less permeable secondary dressing may be required, such as a perforated film absorbent dressing (Melolin or Telfa, for example).
If the wound is very dry, a more occlusive covering may be used to reduce water vapour loss and to prevent the dressing drying out. A film dressing such as Opsite Flexigrid is suitable for this purpose. In the management of difficult wounds such as the hand or foot, the dressing may be retained on the wound in a suitably shaped plastic bag, forming a simple glove or boot . Intrasite may be introduced into narrow wounds or sinuses using a syringe and quill.
Frequency of Change
The interval between dressing changes will depend entirely upon the state of the wound. On heavily exuding or malodorous wounds, daily changes will be required; but on dry wounds, the dressing may be changed on alternate days. It is recommended that the dressing is not left `in-situ` for longer than three days between changes. At the discretion of the medical officer in charge, wounds that show evidence of clinical infection may be dressed with Intrasite, which should be changed daily and systemic antibiotic therapy commenced as appropriate. 
Intrasite may be applied to many different types of wound, including leg ulcers, pressure sores , surgical wounds and extravasation injuries. It is of particular value in the treatment of dry, sloughy, or necrotic wounds, promoting rapid debridement by facilitating rehydration and autolysis of dead tissue. In the management of granulating wounds, Intrasite prevent desiccation, and thus facilitates re-epithelialisation. The gel can form a useful vehicle for the topical application of antimicrobial agents such as metronidazole. Such preparations may be used, in combination with systemic therapy, for the management of wound odour caused by infection with sensitive organisms.
Description
Intrasite, is a colourless transparent aqueous gel, which contains 2.3% of a modified carboxymethylcellulose (CMC) polymer together with propylene glycol (20%) as a humectant and preservative. When placed in contact with a wound, the dressing absorbs excess exudate and produces a moist environment at the surface of the wound, without causing tissue maceration.
Contra-indications:
Although there are no known contra-indications to the use of Intrasite as a topical wound dressing, the material is not ideally suited for application to wounds that are exuding very heavily.
Warnings
Intrasite contains propylene glycol, which has been reported to be a potential irritant and sensitising agent in a very small number of patients. If a patient should exhibit any signs or symptoms of an adverse reaction to Intrasite, treatment should be discontinued at once. Each container should only be used for a single patient, and any unused gel should be discarded.
Dosage
Intrasite should be introduced into the wound to a minimum depth of 5 mm, and covered with a sterile secondary dressing. Any unused dressing should be discarded. The selection of the secondary dressing will be governed by the condition of the wound. If significant quantities of exudate are anticipated, a simple absorbent pad may be used, held in position with tape or a bandage, as appropriate. On lightly exuding wounds, a less permeable secondary dressing may be required, such as a perforated film absorbent dressing (Melolin or Telfa, for example).
If the wound is very dry, a more occlusive covering may be used to reduce water vapour loss and to prevent the dressing drying out. A film dressing such as Opsite Flexigrid is suitable for this purpose. In the management of difficult wounds such as the hand or foot, the dressing may be retained on the wound in a suitably shaped plastic bag, forming a simple glove or boot . Intrasite may be introduced into narrow wounds or sinuses using a syringe and quill.
Frequency of Change
The interval between dressing changes will depend entirely upon the state of the wound. On heavily exuding or malodorous wounds, daily changes will be required; but on dry wounds, the dressing may be changed on alternate days. It is recommended that the dressing is not left `in-situ` for longer than three days between changes. At the discretion of the medical officer in charge, wounds that show evidence of clinical infection may be dressed with Intrasite, which should be changed daily and systemic antibiotic therapy commenced as appropriate.
Intrasite may be applied to many different types of wound, including leg ulcers, pressure sores , surgical wounds and extravasation injuries. It is of particular value in the treatment of dry, sloughy, or necrotic wounds, promoting rapid debridement by facilitating rehydration and autolysis of dead tissue. In the management of granulating wounds, Intrasite prevent desiccation, and thus facilitates re-epithelialisation. The gel can form a useful vehicle for the topical application of antimicrobial agents such as metronidazole. Such preparations may be used, in combination with systemic therapy, for the management of wound odour caused by infection with sensitive organisms.
Description
Intrasite, is a colourless transparent aqueous gel, which contains 2.3% of a modified carboxymethylcellulose (CMC) polymer together with propylene glycol (20%) as a humectant and preservative. When placed in contact with a wound, the dressing absorbs excess exudate and produces a moist environment at the surface of the wound, without causing tissue maceration.
Contra-indications:
Although there are no known contra-indications to the use of Intrasite as a topical wound dressing, the material is not ideally suited for application to wounds that are exuding very heavily.
Warnings
Intrasite contains propylene glycol, which has been reported to be a potential irritant and sensitising agent in a very small number of patients. If a patient should exhibit any signs or symptoms of an adverse reaction to Intrasite, treatment should be discontinued at once. Each container should only be used for a single patient, and any unused gel should be discarded.
Dosage
Intrasite should be introduced into the wound to a minimum depth of 5 mm, and covered with a sterile secondary dressing. Any unused dressing should be discarded. The selection of the secondary dressing will be governed by the condition of the wound. If significant quantities of exudate are anticipated, a simple absorbent pad may be used, held in position with tape or a bandage, as appropriate. On lightly exuding wounds, a less permeable secondary dressing may be required, such as a perforated film absorbent dressing (Melolin or Telfa, for example).
If the wound is very dry, a more occlusive covering may be used to reduce water vapour loss and to prevent the dressing drying out. A film dressing such as Opsite Flexigrid is suitable for this purpose. In the management of difficult wounds such as the hand or foot, the dressing may be retained on the wound in a suitably shaped plastic bag, forming a simple glove or boot . Intrasite may be introduced into narrow wounds or sinuses using a syringe and quill.
Frequency of Change
The interval between dressing changes will depend entirely upon the state of the wound. On heavily exuding or malodorous wounds, daily changes will be required; but on dry wounds, the dressing may be changed on alternate days. It is recommended that the dressing is not left `in-situ` for longer than three days between changes. At the discretion of the medical officer in charge, wounds that show evidence of clinical infection may be dressed with Intrasite, which should be changed daily and systemic antibiotic therapy commenced as appropriate.  |
